97 related articles for article (PubMed ID: 27989895)
1. Intraperitoneal injection of IDO-expressing dermal fibroblasts improves the allograft survival.
Khosravi-Maharlooei M; Pakyari M; Jalili RB; Kilani RT; Ghahary A
Clin Immunol; 2017 Jan; 174():1-9. PubMed ID: 27989895
[TBL] [Abstract][Full Text] [Related]
2. Immunoprotection and Functional Improvement of Allogeneic Islets in Diabetic Mice, Using a Stable Indoleamine 2,3-Dioxygenase Producing Scaffold.
Hosseini-Tabatabaei A; Jalili RB; Khosravi-Maharlooei M; Hartwell R; Kilani RT; Zhang Y; Ghahary A
Transplantation; 2015 Jul; 99(7):1341-8. PubMed ID: 25769070
[TBL] [Abstract][Full Text] [Related]
3. Local expression of indoleamine 2,3 dioxygenase in syngeneic fibroblasts significantly prolongs survival of an engineered three-dimensional islet allograft.
Jalili RB; Forouzandeh F; Rezakhanlou AM; Hartwell R; Medina A; Warnock GL; Larijani B; Ghahary A
Diabetes; 2010 Sep; 59(9):2219-27. PubMed ID: 20522587
[TBL] [Abstract][Full Text] [Related]
4. Suppression of islet allogeneic immune response by indoleamine 2,3 dioxygenase-expressing fibroblasts.
Jalili RB; Rayat GR; Rajotte RV; Ghahary A
J Cell Physiol; 2007 Oct; 213(1):137-43. PubMed ID: 17477384
[TBL] [Abstract][Full Text] [Related]
5. Mouse pancreatic islets are resistant to indoleamine 2,3 dioxygenase-induced general control nonderepressible-2 kinase stress pathway and maintain normal viability and function.
Jalili RB; Forouzandeh F; Moeenrezakhanlou A; Rayat GR; Rajotte RV; Uludag H; Ghahary A
Am J Pathol; 2009 Jan; 174(1):196-205. PubMed ID: 19074614
[TBL] [Abstract][Full Text] [Related]
6. Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses.
Yu G; Dai H; Chen J; Duan L; Gong M; Liu L; Xiong P; Wang CY; Fang M; Gong F
J Gene Med; 2008 Jul; 10(7):754-61. PubMed ID: 18452241
[TBL] [Abstract][Full Text] [Related]
7. Immuno-regulatory function of indoleamine 2,3 dioxygenase through modulation of innate immune responses.
Poormasjedi-Meibod MS; Jalili RB; Hosseini-Tabatabaei A; Hartwell R; Ghahary A
PLoS One; 2013; 8(8):e71044. PubMed ID: 23940687
[TBL] [Abstract][Full Text] [Related]
8. CD11b(+) cells in donor-specific transfusion prolonged allogenic skin graft survival through indoleamine 2,3-dioxygenase.
Ikemoto T; Takita M; Levy MF; Shimada M; Naziruddin B
Cell Immunol; 2013; 283(1-2):81-90. PubMed ID: 23933136
[TBL] [Abstract][Full Text] [Related]
9. IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3+ regulatory T cells.
Xie FT; Cao JS; Zhao J; Yu Y; Qi F; Dai XC
Transpl Immunol; 2015 Oct; 33(2):69-77. PubMed ID: 26002283
[TBL] [Abstract][Full Text] [Related]
10. IDO-Expressing Fibroblasts Protect Islet Beta Cells From Immunological Attack and Reverse Hyperglycemia in Non-Obese Diabetic Mice.
Zhang Y; Jalili RB; Kilani RT; Elizei SS; Farrokhi A; Khosravi-Maharlooei M; Warnock GL; Ao Z; Marzban L; Ghahary A
J Cell Physiol; 2016 Sep; 231(9):1964-73. PubMed ID: 26743772
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast cell-based therapy prevents induction of alopecia areata in an experimental model.
Jalili RB; Kilani RT; Li Y; Khosravi-Maharlooie M; Nabai L; Wang EHC; McElwee KJ; Ghahary A
Cell Transplant; 2018 Jun; 27(6):994-1004. PubMed ID: 29871523
[TBL] [Abstract][Full Text] [Related]
12. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells transfected with indoleamine 2,3-dioxygenase gene suppressed acute rejection of cardiac allograft.
Li C; Liu T; Zhao N; Zhu L; Wang P; Dai X
Int Immunopharmacol; 2016 Jul; 36():31-38. PubMed ID: 27107370
[TBL] [Abstract][Full Text] [Related]
14. Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression.
Paul PK; Das R; Drow T; Nylen EA; de Souza AH; Wang Z; Wood MW; Davis DB; Bjorling DE; Galipeau J
Am J Transplant; 2022 Nov; 22(11):2571-2585. PubMed ID: 35897156
[TBL] [Abstract][Full Text] [Related]
15. Prolonged skin grafts survival time by IFN-γ in allogeneic skin transplantation model during acute rejection through IFN-γ/STAT3/IDO pathway in epidermal layer.
Zhang Y; Wang Y; Wu G; Zhang W; Wang X; Cai W; Zhang J; Han S; Li Y; Bai X; Shi J; Su L; Hu D
Biochem Biophys Res Commun; 2018 Feb; 496(2):436-442. PubMed ID: 29288671
[TBL] [Abstract][Full Text] [Related]
16. Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells.
Yu G; Fang M; Gong M; Liu L; Zhong J; Feng W; Xiong P; Wang CY; Gong F
Transpl Immunol; 2008 Jan; 18(3):208-19. PubMed ID: 18047928
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
[TBL] [Abstract][Full Text] [Related]
18. [EFFECTS OF INDOLEAMINE 2, 3-DIOXYGENASE GENE MODIFIED BONE MARROW MESENCHYMAL STEM CELLS IN RAT COMPOSITE TISSUE ALLOGRAFT REJECTION].
Han F; Wang Y; Wang Y; Jia Y; Yang L; Jia W; Fang X; Bai X; Hu D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jun; 28(6):745-51. PubMed ID: 26455230
[TBL] [Abstract][Full Text] [Related]
19. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression.
Beutelspacher SC; Pillai R; Watson MP; Tan PH; Tsang J; McClure MO; George AJ; Larkin DF
Eur J Immunol; 2006 Mar; 36(3):690-700. PubMed ID: 16482510
[TBL] [Abstract][Full Text] [Related]
20. Topical application of soluble CD83 induces IDO-mediated immune modulation, increases Foxp3+ T cells, and prolongs allogeneic corneal graft survival.
Bock F; Rössner S; Onderka J; Lechmann M; Pallotta MT; Fallarino F; Boon L; Nicolette C; DeBenedette MA; Tcherepanova IY; Grohmann U; Steinkasserer A; Cursiefen C; Zinser E
J Immunol; 2013 Aug; 191(4):1965-75. PubMed ID: 23851696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
